Morita M, Kato M, Kuji S, Hasuda A
Department of Urology, Sendai Social Insurance Hospital.
Hinyokika Kiyo. 1988 Jul;34(7):1293-6.
The penetration of enoxacin into prostatic tissue was examined Thirty-five patients with benign prostatic hypertrophy entered the study. Enoxacin was administered orally in a dose of 200 mg three times daily for 3 days preoperatively. Blood samples were taken simultaneously at the time of tissue sampling. The patients were divided into groups 1 and 2. In group 1, tissue sampling was done after about 17 hours of final administration of the drug. The mean concentration of enoxacin in prostatic tissue was 1.87 +/- 1.23 micrograms/g and 1.05 +/- 0.458 micrograms/ml in serum. In group 2, sampling was done after 5.5 hours of final administration. The mean concentration of enoxacin in prostatic tissue was 2.51 +/- 0.725 micrograms/g and 1.78 +/- 0.586 micrograms/ml in serum.
检测了依诺沙星在前列腺组织中的渗透情况。35例良性前列腺增生患者进入该研究。术前3天,依诺沙星以每日3次、每次200mg的剂量口服给药。在采集组织样本时同时采集血样。患者被分为1组和2组。在1组中,在最后一次给药约17小时后进行组织采样。前列腺组织中依诺沙星的平均浓度为1.87±1.23微克/克,血清中为1.05±0.458微克/毫升。在2组中,在最后一次给药5.5小时后进行采样。前列腺组织中依诺沙星的平均浓度为2.51±0.725微克/克,血清中为1.78±0.586微克/毫升。